NANX Nanophase Technologies Corp.

Solésence Beauty Science to Exhibit Cosmetics Infused with SPF at MakeUp In New York

Solésence Beauty Science to Exhibit Cosmetics Infused with SPF at MakeUp In New York

ROMEOVILLE, Ill., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced that Solésence Beauty Science will be exhibiting at MakeUp in New York on September 14th and 15th, 2022.

MakeUp in New York is “a professional and convivial event connecting the most innovative and talented cosmetic suppliers with the most successful skincare and make-up brands,” according to . Solésence Beauty Science, a leader in inclusive, mineral-based beauty products for skincare and makeup brands, will be exhibiting at MakeUp in New York for the first time. Solésence will showcase its market-ready products that embrace self-expression, health care, and self-care, blurring skin care with color cosmetics while providing best-in-class UV and environmental protection. Their award-winning formula, Multi-Cultural Magic SPF 50+ featuring Kleair™, will be at the show.

The announcement comes on the heels of Solésence being shortlisted as a finalist for Best Contract Manufacturer in the BeautyMatter NEXT Awards.

“We are thrilled to join other industry leaders across makeup and skincare categories at MakeUp in New York. We chose to participate on a last-minute basis in response to requests from both current and prospective brand partners. Coupled with the increased interest in SPF-infused beauty products across the industry, we are expecting a busy show. We look forward to seeing familiar faces as well as making the acquaintance of some new ones,” commented Kevin Cureton, Chief Operating Officer.

About Solésence Beauty Science

Solésence, LLC, , a wholly owned subsidiary of Nanophase Technologies, is changing the face of skin health with patented, mineral-based technology that is embraced by leading performance-driven and clean beauty brands alike. Our patented products for brands transform the way mineral actives look, feel and function — enabling textures never-before-seen in the mineral space and inclusivity never-before-seen in the sun care space. Solésence’s innovative formulations offer best-in-class UV protection, unparalleled free radical prevention to protect against pollution, and enhanced antioxidant performance.

About Nanophase Technologies

Nanophase Technologies Corporation (OTCQB: NANX), , is a leading innovator in minerals-based and scientifically driven health care solutions across beauty and life science categories, as well as other legacy advanced materials applications. Leveraging a platform of integrated, patented, and proprietary technologies, the Company creates products with unique performance, enhancing consumers' health and wellbeing. We deliver commercial quantity and quality engineered materials both as ingredients and as part of fully formulated products in a variety of formats.

Forward-Looking Statements

This press release contains words such as “expects,” shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance, and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s engineered materials, ingredients, and fully formulated products; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company’s Form 10-K filed March 31, 2022. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, or other contingencies.

Media Contact:

Emma Harper

Email:

Phone: (630) 686-1574

Investor Relations Contact:

Phone: (630) 771-6736



EN
13/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nanophase Technologies Corp.

 PRESS RELEASE

Solésence Reports Record First Quarter 2025 Financial Results

Solésence Reports Record First Quarter 2025 Financial Results First quarter revenue increased 48% to a record $14.6 million ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2025.    Recent Highlights and Accomplishments Uplisted to Nasdaq under the ticker “SLSN” supporting the Company’s increased visibility with the investment communityAchieved record revenue and unit volume shipments...

 PRESS RELEASE

Solésence To Report First Quarter 2025 Financial Results and Host a Co...

Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2025 after the market close on Monday, May 5, 2025, and host a conference call and webcast on the same date. First Quarter 2025 Conference Call Details Date / Time: Monday, May 5, 2025 - 4:00 p.m. CDT, 5:00 p.m. ...

 PRESS RELEASE

Solésence Announces Uplisting to Nasdaq

Solésence Announces Uplisting to Nasdaq Trading set to begin Tuesday, April 8 under new ticker “SLSN” ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has received approval from the Listing Qualifications Department of Nasdaq to transfer its listing to the Nasdaq Capital Market. The Company’s securities will be uplisted to Nasdaq at the opening of business on Tuesday, April 8, 2025. Prior to listing on Nasdaq, the Company’s shares t...

 PRESS RELEASE

Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial R...

Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results Fourth quarter revenue increased 58% to a record $12.6 million Full Year 2024 revenue increased 40% to a record $52.3 million ROMEOVILLE, Ill., March 26, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the fourth quarter and year ended December 31, 2024.    Recent Highlights and Accomplishments Company rebranded as Solésence, Inc., marking a new era of innovation, se...

 PRESS RELEASE

Solésence To Report Fourth Quarter and Full Year 2024 Financial Result...

Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call ROMEOVILLE, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the fourth quarter and full year 2024 after the market close on Wednesday, March 26, 2025, and host a conference call and webcast on Thursday, March 27. Fourth Quarter 2024 Conference Call Details Date / Time: Thursday, March 27, 2025 - 7:00 a.m. CDT, 8:...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch